These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 28645936)
1. Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients. Yang LY; Yu CG; Wang XH; Yuan SS; Zhang LJ; Lang JN; Zhao D; Feng YM J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645936 [TBL] [Abstract][Full Text] [Related]
2. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients. Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179 [TBL] [Abstract][Full Text] [Related]
3. Plasma angiopoietin-like 4 is related to phospholipid transfer protein activity in diabetic and non-diabetic subjects: role of enhanced low grade inflammation. Gruppen EG; Kersten S; Dullaart RPF Lipids Health Dis; 2018 Mar; 17(1):60. PubMed ID: 29587751 [TBL] [Abstract][Full Text] [Related]
4. ANGPTL3 is a novel HDL component that regulates HDL function. Yang L; Wang Y; Xu Y; Li K; Yin R; Zhang L; Wang D; Wei L; Lang J; Cheng Y; Wang L; Ke J; Zhao D J Transl Med; 2024 Mar; 22(1):263. PubMed ID: 38462608 [TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity. Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Konrad RJ Heliyon; 2021 Sep; 7(9):e07898. PubMed ID: 34504977 [TBL] [Abstract][Full Text] [Related]
6. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway. Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895 [TBL] [Abstract][Full Text] [Related]
7. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Mehta N; Qamar A; Qu L; Qasim AN; Mehta NN; Reilly MP; Rader DJ Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1057-63. PubMed ID: 24626437 [TBL] [Abstract][Full Text] [Related]
8. Novel Insights of ANGPTL-3 on Modulating Cholesterol Efflux Capacity Induced by HDL Particle. Lai M; Jiang X; Wang B; Cheng Y; Su X Curr Mol Med; 2024; 24(6):771-779. PubMed ID: 37073658 [TBL] [Abstract][Full Text] [Related]
9. Effect of mountain ultra-marathon running on plasma angiopoietin-like protein 4 and lipid profile in healthy trained men. Górecka M; Krzemiński K; Buraczewska M; Kozacz A; Dąbrowski J; Ziemba AW Eur J Appl Physiol; 2020 Jan; 120(1):117-125. PubMed ID: 31707478 [TBL] [Abstract][Full Text] [Related]
10. Circulating and tissue specific transcription of angiopoietin-like protein 4 in human Type 2 diabetes. McCulloch LJ; Bramwell LR; Knight B; Kos K Metabolism; 2020 May; 106():154192. PubMed ID: 32112823 [TBL] [Abstract][Full Text] [Related]
11. Increased plasma and adipose tissue levels of ANGPTL8/Betatrophin and ANGPTL4 in people with hypertension. Abu-Farha M; Cherian P; Qaddoumi MG; AlKhairi I; Sriraman D; Alanbaei M; Abubaker J Lipids Health Dis; 2018 Mar; 17(1):35. PubMed ID: 29490644 [TBL] [Abstract][Full Text] [Related]
12. Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins. Brown RJ; Lagor WR; Sankaranaravanan S; Yasuda T; Quertermous T; Rothblat GH; Rader DJ Circ Res; 2010 Aug; 107(3):357-64. PubMed ID: 20558822 [TBL] [Abstract][Full Text] [Related]
13. A novel endothelial-derived lipase that modulates HDL metabolism. Jaye M; Lynch KJ; Krawiec J; Marchadier D; Maugeais C; Doan K; South V; Amin D; Perrone M; Rader DJ Nat Genet; 1999 Apr; 21(4):424-8. PubMed ID: 10192396 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia. Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117 [TBL] [Abstract][Full Text] [Related]
15. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus. Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150 [TBL] [Abstract][Full Text] [Related]
16. The WWOX gene modulates high-density lipoprotein and lipid metabolism. Iatan I; Choi HY; Ruel I; Reddy MV; Kil H; Lee J; Odeh MA; Salah Z; Abu-Remaileh M; Weissglas-Volkov D; Nikkola E; Civelek M; Awan Z; Croce CM; Aqeilan RI; Pajukanta P; Aldaz CM; Genest J Circ Cardiovasc Genet; 2014 Aug; 7(4):491-504. PubMed ID: 24871327 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-134 Promotes the Development of Atherosclerosis Via the ANGPTL4/LPL Pathway in Apolipoprotein E Knockout Mice. Ye Q; Tian GP; Cheng HP; Zhang X; Ou X; Yu XH; Tan RQ; Yang FY; Gong D; Huang C; Pan YJ; Zhang J; Chen LY; Zhao ZW; Xie W; Li L; Zhang M; Xia XD; Zheng XL; Tang CK J Atheroscler Thromb; 2018 Mar; 25(3):244-253. PubMed ID: 28867683 [TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma. El-Shal AS; Zidan HE; Rashad NM; Wadea FM Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666 [TBL] [Abstract][Full Text] [Related]
19. Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice. Adachi H; Kondo T; Koh GY; Nagy A; Oike Y; Araki E Biochem Biophys Res Commun; 2011 Jun; 409(2):177-80. PubMed ID: 21549101 [TBL] [Abstract][Full Text] [Related]
20. Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue. Dijk W; Schutte S; Aarts EO; Janssen IMC; Afman L; Kersten S J Clin Lipidol; 2018; 12(3):773-783. PubMed ID: 29555209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]